175 related articles for article (PubMed ID: 11924631)
21. Hematopoietic stem cell transplantation: 40 years of continuous progress and evolution.
Porta F; Locatelli F; Burgio GR
Haematologica; 2008 Nov; 93(11):1607-10. PubMed ID: 18978297
[No Abstract] [Full Text] [Related]
22. Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen.
Dey BR; Shaffer J; Yee AJ; McAfee S; Caron M; Power K; Ting DT; Colby C; Preffer F; Ballen K; Attar E; Saidman S; Tarbell N; Sachs D; Sykes M; Spitzer TR
Bone Marrow Transplant; 2007 Jul; 40(1):19-27. PubMed ID: 17468773
[TBL] [Abstract][Full Text] [Related]
23. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
24. A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients.
Tsirigotis P; Bitan RO; Resnick IB; Samuel S; Ackerstein A; Eladì S; Gesundheit B; Zilberman I; Miron S; Leubovic A; Slavin S; Shapira MY
Haematologica; 2006 Jun; 91(6):852-5. PubMed ID: 16769592
[TBL] [Abstract][Full Text] [Related]
25. Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series.
Cesaro S; Pillon M; Visintin G; Putti MC; Gazzola MV; D'Amore E; Scarzello G; Zanesco L; Messina C; Rosolen A
Eur J Haematol; 2005 Jul; 75(1):22-6. PubMed ID: 15946306
[TBL] [Abstract][Full Text] [Related]
26. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey.
Gratwohl A; Baldomero H; Passweg J; Urbano-Ispizua A;
Bone Marrow Transplant; 2002 Dec; 30(12):813-31. PubMed ID: 12476273
[TBL] [Abstract][Full Text] [Related]
27. [Choice of stem cell source in hematopoietic cell transplantation].
Yabe H
Rinsho Ketsueki; 2005 Jun; 46(6):399-409. PubMed ID: 16447721
[No Abstract] [Full Text] [Related]
28. [Recent progress in hematopoietic stem cell transplantation].
Shinagawa K
Gan To Kagaku Ryoho; 2006 Jun; 33(6):727-35. PubMed ID: 16770089
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
[TBL] [Abstract][Full Text] [Related]
30. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO).
Dini G; Cancedda R; Giorgiani G; Porta F; Messina C; Uderzo C; Pession A; Fagioli F; La Nasa G; Arcese W; Pollichieni S; Zecca M; Lanino E; Mazzolari E; Cesaro S; Balduzzi A; Rondelli R; Vassallo E; Cappelli B; Locatelli F;
Haematologica; 2002 Aug; 87(8 Suppl):51-7. PubMed ID: 12412391
[TBL] [Abstract][Full Text] [Related]
31. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
[TBL] [Abstract][Full Text] [Related]
32. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
33. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
34. Umbilical cord blood transplantation--how, when and for whom?
Cohen Y; Nagler A
Blood Rev; 2004 Sep; 18(3):167-79. PubMed ID: 15183901
[TBL] [Abstract][Full Text] [Related]
35. [Allogenic bone marrow transplantation].
Yamane T; Im T; Nakao T; Kumura T; Tatsumi N
Rinsho Byori; 1995 Jul; Suppl 99():15-23. PubMed ID: 7474421
[No Abstract] [Full Text] [Related]
36. Future directions of bone marrow transplantation.
Buskard NA
CMAJ; 1987 Aug; 137(4):277-9. PubMed ID: 3300925
[No Abstract] [Full Text] [Related]
37. [Bone marrow transplantation].
Rozman C
Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(3):125-40. PubMed ID: 3912945
[No Abstract] [Full Text] [Related]
38. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
39. OTI-010 Osiris Therapeutics/JCR Pharmaceuticals.
Taupin P
Curr Opin Investig Drugs; 2006 May; 7(5):473-81. PubMed ID: 16729725
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic transplantation for bone marrow failure syndromes and thalassemia.
Sevilla J; Fernández-Plaza S; Diaz MA; Madero L;
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S17-21. PubMed ID: 15812523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]